Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Global Blood Therapeutics Inc. (GBT)’

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

13G Filing: Perceptive Advisors and Global Blood Therapeutics Inc (GBT)

Global Blood Therapeutics Inc (NASDAQ:GBT): Joseph Edelman’s Perceptive Advisors filed an amended 13D. You can check out Perceptive Advisors’......(read more)
Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

13G Filing: Point72 Asset Management and Global Blood Therapeutics Inc. (GBT)

Global Blood Therapeutics Inc (NASDAQ:GBT): Steve Cohen’s Point72 Asset Management filed an amended 13D. You can check out Point72 Asset Management......(read more)
Best Bumble Bios For Girls

5 Stocks The Best Performing Hedge Funds Are Piling Into

At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using......(read more)
Easiest Md/PhD Programs to Get Into

Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors

Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma......(read more)
paypal, buy, rose, business, app, editorial, technology, touch, computer, phablet, mobile, woman, electronic, smartphone, payment, purchase, background, device, online,

Here’s Why Global Blood, Deutsche Bank, PayPal, and Two Other Stocks Are Trending Today

Amid another spate of earnings releases all three main stock indexes are trading lower today. The Dow Jones is down by 0.21%, the S&P 500 is 0.30......(read more)
pharmaceuticals-385956_1280

5 Stocks That Healthcare Fund Deerfield Management Was Buying in Q2

Founded by James E. Flynn in 2000, Deerfield Management has grown to become one of the premier healthcare-focused investment management companies today......(read more)
biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Movers and Shakers in Biotech: Global Blood Therapeutics Inc (GBT) and Eleven Biotherapeutics Inc (EBIO)

It’s the start of a new week in biotech, and a number of potential catalysts promise to inject some volatility into the space going forward. A few companies......(read more)
dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Here’s What To Watch From Global Blood Therapeutics Inc (GBT)

Global Blood Therapeutics Inc (NASDAQ:GBT) just kicked off a phase IIa trial in its lead sickle cell candidate, GBT440. Sickle cell is one of the most......(read more)
market, stock, money, index, graph, credit, globe, advisor, economics, ticker, business, income, arrow, success, diagram, wealth, data, analysis, report, monitoring,

Market Defying Stocks: Why Axiall, Connecture, and 3 Other Stocks Are Rising on a Red Day

It’s been a volatile day on Wall Street as the markets initially sold off sharply on fears of the consequences of a potential Brexit. The markets......(read more)
James Flynn Deerfield Management

Deerfield Management Discloses 3.66% Stake In Newly Public Company Global Blood Therapeutics Inc. (GBT)

James E. Flynn’s Deerfield Management has filed a Schedule 13G disclosing a 3.66% ownership stake in the newly public company Global Blood Therapeutics......(read more)